Table 4. Costs, maternal health outcomes and cost-effectiveness ratios of options A and B and Malawi's Option B+ for the ten-year horizon (US $ 2010).
Current Practice | Option A | Option B | Option B+ | |
Costs | ||||
PMTCT costs (first 18 months) | $ 3,672,594 | $ 13,172,855 | $ 21,290,738 | $ 20,093,738 |
Cost of ART for eligible women (subsequent years) | $ 10,162,136 | $ 26,639,260 | $ 26,837,855 | $ 73,852,060 |
Cost of follow up and monitoring | $ 448,525 | $ 1,692,548 | $ 1,692,548 | $ 3,784,190 |
Total programme costs (10 years) | $ 14,283,255 | $ 41,504,663 | $ 49,821,141 | $ 97,729,988 |
Outcomes | ||||
Number of HIV infected women on ART and alive after ten years | 18,267 | 28,567 | 30,057 | 42,137 |
Life years gained in HIV infected mothers after ten years | 66,289 | 152,966 | 171,543 | 249,576 |
Cost-Effectiveness Ratios | ||||
ICER per life year gained (compared to the current practice) | - | $ 314 | $ 338 | $ 455 |